Olivia Fuentes-Ríos

5PUBLICATIONS
159CO-AUTHORS
Radiation therapyCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 13, 2026
Circadian genotypes in PER3 and time of prostate cancer radiotherapy interact to affect risk of late side-effects.

|Jan 07, 2026
Splicing Predictions, Splicing Assays, and Variant Classification Using ACMG/AMP Guidelines: Challenges Observed with BRCA1 and BRCA2 Variants.

Marta Santamariña, Olivia Fuentes-Ríos, Ana Blanco-Pérez

|Mar 03, 2025
A Polygenic Risk Score for Late Bladder Toxicity Following Radiotherapy for Non-Metastatic Prostate Cancer.

Manzur Farazi, Xin Yang, Carson J Gehl

|Jan 06, 2025
Association of radiation-induced normal tissue toxicity with a high genetic risk for rheumatoid arthritis.

Alan McWilliam, Deborah Marshall, Sarah L Kerns

|Jul 14, 2023
ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk.

Lenka Stolarova, Petra Kleiblova, Petra Zemankova

Pageof 1

Frequent Collaborators

5 joint publications

Ana Vega

4 joint publications

Miguel E Aguado-Barrera

3 joint publications

Christopher Talbot

3 joint publications

Liv Veldeman